Julie Aker to speak at Brookings to discuss REMS

Posted September 19th, 2013. Filed under Concentrics News

Julie Aker, President & CEO, has been invited to speak at the Brookings Institution in Washington, D.C on September 25th and to be part of an expert panel to discuss the REMS (Risk Evaluation and Mitigation Strategies) process.  This process has been arduous for many sponsors.  Brookings is convening a group of FDA and industry experts to evaluate the current process and explore possibilities for improvement.